One study suggests that ALS patients with elevated CRP levels have faster disease progression than those with lower CRP levels and that serum CRP may be a prognostic biomarker in ALS (Lunetta et al., 2017). The gene discussed is CRP; the disease is amyotrophic lateral sclerosis.